A Study to Evaluate the Efficacy, Durability, and Safety of KSI-301 Compared to Aflibercept in Patients With Macular Edema Due to Retinal Vein Occlusion (RVO)
Trial details
- Registry ID
- NCT04592419
- Phase
- Phase 3
Drug identity has not yet been verified against registry records
| No regulatory events match this view.This does not mean no FDA events have occurred. |